A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients. Regulation and Deregulation of Industry, Genetic Engineering, United States Politics and Government, Deaths (Fatalities), Muscular Dystrophy, Men and Boys, Drugs (Pharmaceuticals), Food and Drug Administration, , Prasad, Vinayak K Read More
F.D.A. Sharply Limits Use of Drug Linked to Two Teen Deaths
